Hyperactivation of KRAS signaling, which is usually caused by mutations of the KRAS gene, is commonly observed in cancer to drive uncontrolled cell proliferation and metastasis[13, 14].The KRAS G12C mutation is one of the most extensively studied oncogenic driver mutations. This evidence concerns the gene KRAS and cancer.